A share price of RAPT Therapeutics Inc [RAPT] is currently trading at $1.69, down -6.63%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RAPT shares have gain 109.21% over the last week, with a monthly amount glided 50.89%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
RAPT Therapeutics Inc [NASDAQ: RAPT] stock has seen the most recent analyst activity on December 26, 2024, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $10 for it. Previously, Stifel downgraded its rating to Hold on November 13, 2024, and dropped its price target to $2. On November 11, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $2 on the stock. JP Morgan downgraded its rating to a Underweight. Wolfe Research downgraded its rating to a Peer Perform. Guggenheim downgraded its rating to Neutral for this stock on May 10, 2024. In a note dated May 10, 2024, Barclays downgraded an Equal Weight rating on this stock and revised its target price from $13 to $4.
RAPT Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.79 and $27.35. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. RAPT Therapeutics Inc [NASDAQ: RAPT] shares were valued at $1.69 at the most recent close of the market. An investor can expect a potential return of 18.34% based on the average RAPT price forecast.
Analyzing the RAPT fundamentals
Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -21.72%, Pretax Profit Margin comes in at -20.33%, and Net Profit Margin reading is -20.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.99, Equity is -0.89 and Total Capital is -1.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6067 points at the first support level, and at 1.5233 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8567, and for the 2nd resistance point, it is at 2.0233.
Ratios To Look Out For
To put it in perspective, the Current Ratio for RAPT Therapeutics Inc [NASDAQ:RAPT] is 9.90. Further, the Quick Ratio stands at 9.90, while the Cash Ratio is 3.66.
Transactions by insiders
Recent insider trading involved Brockstedt Dirk G., CHIEF SCIENTIFIC OFFICER, that happened on Jan 05 ’24 when 898.0 shares were sold.
